ESP | ENG

Vasculitis Induced by Anti-TNF Agents (31-08-07)

First author	Year	Patients	Age	Gender	Rheumatic disease	Anti-TNF administered
Ashok	2007	1	35	M	RA	Infliximab
Leydet	2007	1	82	F	RA	Etanercept
Lebas	2007	2	NA	NA	NA	NA
Ruppert	2006	1	45	F	RA	Infliximab
Duffy	2006	1	NE	NE	RA	Etanercept
Lee	2006	1	NE	NE	Ps	Etanercept
Martinez-Taboada	2006	1	59	F	RA	Etanercept
Orpin	2006	1	44	F	RA	Adalimumab
Saint Marcoux	2006	39	51,6	32F 7M	34RA 2JRA 2AS 1PsA	21Etanercept 15Infliximab 2Adalimumab 1other
Tektonidou	2006	1	56	F	RA	Inflximab
Tektonidou	2006	1	60	M	RA	Infliximab
Wendling	2006	1	29	F	RA	Infliximab
Anandacoomarasamy	2005	1	62	F	RA	Infliximab
Flendrie	2005	1	NE	NE	RA	Infliximab
Flendrie	2005	1	NE	NE	RA	Etanercept
Flendrie	2005	1	NE	NE	RA	Adalimumab
Flendrie	2005	1	NE	NE	RA	Adalimumab
Flendrie	2005	1	NE	NE	RA	Lenercept
Juan	2005	1	60	M	RA	Etanercept
Mor	2005	1	22	F	JRA	Etanercept
Srivastava	2005	1	36	F	CD	Inflliximab
Doulton	2004	1	32	F	RA	Etanercept
Mohan	2004	15	NE	13F 2M	8RA 1AS 1PsA 5CD	Infliximab
Mohan	2004	20	NE	16F 4M	18RA 2JRA	Etanercept
Richette	2004	1	41	F	RA	Infliximab
Richette	2004	1	48	F	RA	Infliximab
Roux	2004	1	43	F	RA	Etanercept
Seton	2004	1	79	F	RA	Etanercept
Stokes	2004	1	64	F	RA	Infliximab
Stokes	2004	1	55	M	RA	Etanercept
Stokes	2004	1	53	F	RA	Etanercept
Jarrett	2003	1	NE	NE	RA	Etanercept
Jarrett	2003	7	NE	NE	7RA	Infliximab
McIlwain	2003	1	24	F	CD	Infliximab
Swale	2003	1	55	F	RA	Etanercept
Cunname	2002	1	50	M	RA	Etanercept
Cunname	2002	1	67	M	RA	Etanercept
McCain	2002	1	73	F	RA	Etanercept
Galaria	2000	1	58	M	RA	Etanercept
Brion	1999	1	58	F	RA	Etanercept

b) Classification